10th International Inter University Scientific Meeting
Academy of Studenica
PERSPECTIVES IN MELANOMA MANAGEMENT
& NANOTECHNOLOGY IN BIOMEDICINE

Organizers: Institute of Oncology Sremska Kamenica; Union of Cancer Prevention
Societies of Vojvodina, Novi Sad; Clinic of Oncology, Nis; Institute for Oncology and Radiology of Serbia, Belgrade Center for Bioengineering, Faculty of Mechanical Engineering, University of Belgrade

President: Vladimir Baltic Vice-presidents: Zlata Janjic, Radan Dzodic, Borislava Nikolin; Djuro Koruga
ISSN 1450-708

Content
7 /2004
 
PREGNANCY AND MALIGNANT MELANOMA
Potić-Zečević N, Stanojević Z, Marković M, Todorovska I, *Stanojević M.

Clinic of Oncology, Clinical Centre Niš, Niš, Serbia and Montenegro
* Clinic od Dermatovenerology, Clinical Centre Niš, Niš, Serbia and Montenegro
 
  ABSTRACT
Malignant melanoma of skin is a tumor particulary common in white-skined populations living in sunny climates.Thus, high rates of incidence are found in Australia and New Zealand (age-standardised incidence rate 39.9 in men and 32.3 in women) and North America (12.74 in men and 9.26 in women).Skin melanoma has a high survival rate in developed areas with the best rates in Australia and New Zealand (85%), and in developing countries is poorer (about 40%). Thus, the range of mortality rates among areas of the world is much less then of incidence rates. In all, 132 602 new cases are estimated annualy (with slightly more in women then in men) and 37 047 deaths, more of which occur in men.
In order to find out the epidemiology situation concerning malignant melanoma in Niš, we undertook a retrospective analysis of newly registered cases over a period of five years (1999-2003.) The data were obtained from the Hospital Cancer Registry Clinic of oncology Niš.
During the observed period (1999-2003.) there were 8048 reported new cases (2931 men and 5117 women). Malignant melanoma of skin were reported with 195 newly cases. According to the total number of registered cases, malignant melanoma took the 13th places (both gender) with 2,4%. In the precentage structure of all cancer sites, malignant melanoma are represented with 3,1% in men (10th place) and 2,03% in women (8th place). In analysing period, 91 cases of malignant melanoma were reported in men and 104 women, sex ratio 1:1,14. The number of newly cases changed over the observed period, showing a slightly increase by both gender, with the lowest values in 1999. (34 patients) and the highest values in 2003. (55 patients). The number of malignant melanoma increase with age, most rapidly after the age of 60 (53 cases). The body site distribution differs between sex and malignant melanoma is more common on the trunck (25%) in men and on the lower limbs in women (19%).
According the such epidemiological data it can be concluded that the region of Nis is not a region with an important risk for malignant melanoma of skin.
  Keywords: Malignant melanoma, Epidemiology  
© Academy of Studenica, 2004